Evidence map›Paper›PMID 41723450›Full record

Observational studyBMC medical informatics and decision making2026

Quality evaluation of online platforms information for retail of prescription medicines in China: an observational study of the case of paroxetine.

Han Yao, Chutong Li, Xiaonan Shi, Bo Peng, Zhenyang Kang, Jing Sun, Yuanli Liu

Abstract readObservational Study
In one paragraph

Observational study in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Han YaoSchool of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Chutong LiSchool of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Xiaonan ShiSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Bo PengNational Research Institute for Family Planning, Beijing, 100081, China.
Zhenyang KangNational Research Institute for Family Planning, Beijing, 100081, China.
Jing SunSchool of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China. sunjing@sph.pumc.edu.cn.
Yuanli LiuSchool of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China. liuyuanli_pumc@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to generate evidence to help improve the quality of information provided by Chinese online platforms for retail of prescription medicines, as a baseline for enhancing the supervision by the regulatory authorities of internet retail of prescription medicines to offer comprehensive, accurate and reliable information to consumers.

methodsThis is an observational study to investigate the quality of the information provided by two key types of online platforms in China that sell paroxetine online, a common mental health medication. The authors utilized the DISCERN with the Likert 5 scale, a validated instrument comprising three domains and 16 items to assess the comprehensiveness, accuracy and reliability of information provided by a total of 34 Chinese online platforms. We firstly examined whether these online platforms have been diligent in their duty to provide appropriate retail service-related information (e.g. delivery, payment, return policies) for prescription medications. We also evaluated the quality of the medication information associated with treatment plans for specific prescriptions provided by the online platforms. Three trained master medical students independently conducted the evaluation. By securing the consistency of the scoring results among different evaluators and the reliability of the evaluation, we adopted the mean score of the three evaluators for each item to perform further analysis at the item and domain levels, and between two types of online platforms.

resultsAmong the 34 online platforms, 2 were evaluated as providing excellent information for retail of paroxetine (1/34, 5.88%), 6 were good (6/34, 17.65%), 25 were fair (25/34, 73.53%), and 1 was poor (1/34, 2.94%). The key identified flaws of the online platforms for providing appropriate information for retail of paroxetine included (1) inadequate provision of medication information, (2) absence of prescription validation and authentication, and (3) lack of professional pharmacy services such as mandatory pharmacist consultations or patient-specific drug counselling.

conclusionsConsumers face challenges in obtaining comprehensive, accurate and reliable information from the online platforms for common mental health prescription medications. The quality of information provided by the online platforms for retail of prescription medicines is generally suboptimal, and the compliance of prescription validation and authentication is problematic. These highlight the need for strengthening the supervision of the online platforms with novel approaches along with their rapid developments, and ensuring appropriate online information provided to consumers.

Indexed as

InternetParoxetinePrescription DrugsChinaHumansParoxetinePrescription DrugsDISCERNE-commerceInformationOnlineParoxetine hydrochloridePlatformPrescription medicinesQualityRetail

Identifiers

PMID41723450
PMCPMC13032684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.